CClinicalTrials.gg
CompletedNCT05299320Updated Jul 26, 2022

Postural Control in Covid-19

An observational study in COVID-19 and Performance, sponsored by Karamanoğlu Mehmetbey University. Completed at 2 sites in Turkey. Open to female participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-26.

Sponsored by Karamanoğlu Mehmetbey University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
56
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

This study was planned to investigate how much the anaerobic performance of individuals who experienced fatigue with Want (Wingate) affected their postural sway parameters.

Read the detailed description

The postural sway parameters of the individuals will be evaluated using the "Kistler Force Plate" and the anaerobic values will be evaluated using the Wingate Anaerobic Strength Test and the "Excalibur Sport Ergometer" device. The data obtained will be compared with the data of patients with and without Covid-19 disease using appropriate statistical methods.

02

Conditions studied

  • COVID-19
  • Performance

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 56 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Karamanoğlu Mehmetbey University is the lead sponsor of 65 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with covid-19 and Have not had covid 19 before

Inclusion criteria

  • Being between the ages of 18-30, - Being a volunteer - Having had Covid 19 in the last 3 month

Exclusion criteria

Exclusion Criteria:

  • Presence of neurologic and oncologic disease - Presence of orthopedic surgery - Presence of active Covid 19 disease - Any cardiopulmonary disease
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
56 participants (actual)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • Patients with Post-Covid

    Being between the ages of 18-30, - Being a volunteer - Having had Covid-19 in the last 3 month Exclusion Criteria - Presence of neurologic and oncologic disease - Presence of orthopedic surgery - Presence of active Covid-19 disease - Any cardiopulmonary disease

    Diagnostic Test: Neuromuscular fatigue and postural sway evaluation

  • Healthy Person

    Being between the ages of 18-30, Being a volunteer, not having Covid-19 before

    Diagnostic Test: Neuromuscular fatigue and postural sway evaluation

Interventions

  • Diagnostic testNeuromuscular fatigue and postural sway evaluation

    Neuromuscular fatigue will be established by using the Excalibur Sport Ergometer device and the Wingate Anaerobic Strength Test. Postural sway will be evaluated with Cyst Force Plate Balance device. This device is a precision device that provides objective measurable data.

    Also known as: Postural sway, Postural sway evaluation

06

What researchers measure

Primary outcomes

  1. Postural Sway

    Postural sway will be evaluated with Cyst Force Plate Balance device. This device is a precision device that provides objectively measurable data. Thanks to its movable platform, it can measure in all directions. Participants will be asked to stand on the platform assessing their body oscillations. They will be asked to look at a still picture on the wall with their arms at the iliac and eyes directly opposite them. Individuals will be asked to keep their designated positions for 30 seconds. At the end of the specified period, the data obtained from the device will be saved. Before and after the neuromuscular fatigue test postural sway will be evaluated.

    Time frame: 3 months

07

Study locations

2 sites
  • Karamanoglu Mehmetbey University
    Karaman, Turkey
  • Karamanoğlu Mehmetbey University
    Karaman, Turkey
08

References and documents

Publications

  • Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626-631. doi: 10.1038/s41591-021-01292-y. Epub 2021 Mar 10. Erratum In: Nat Med. 2021 Jun;27(6):1116. doi: 10.1038/s41591-021-01361-2. PubMed 33692530 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05299320
Lead sponsor
Karamanoğlu Mehmetbey University
Responsible party
Hikmet Kocaman (Head of study Dr. Hikmet Kocaman, Karamanoğlu Mehmetbey University) — Principal investigator
First posted
Mar 29, 2022
Start date
Mar 2, 2022
Primary completion
Jun 10, 2022
Completion
Jun 20, 2022
Last update
Jul 26, 2022

Study contacts

Ayşenur Gökşen, PhD
study chair · Tarsus Universty

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion